Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., . . . Payami, H. (2017). Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement disorders, 32(5), 739-749. https://doi.org/10.1002/mds.26942
Citácia podle Chicago (17th ed.)Hill‐Burns, Erin M., et al. "Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome." Movement Disorders 32, no. 5 (2017): 739-749. https://doi.org/10.1002/mds.26942.
Citácia podľa MLA (8th ed.)Hill‐Burns, Erin M., et al. "Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome." Movement Disorders, vol. 32, no. 5, 2017, pp. 739-749, https://doi.org/10.1002/mds.26942.